|
|
Publications
Peloquin
CA, Berning SE, Nitta AT,
Simone PM, Goble M, Huitt GA, Iseman MD, Cook JL, Curran-Everett D.
Aminoglycoside toxicity: daily versus thrice-weekly dosing for
treatment of mycobacterial diseases. Clin
Infect Dis 2004;38:1538-1544.
Nitta AT, Kim J.
Limited transmission of multidrug-resistant tuberculosis (letter).
Am J Respir Crit Care Med 2003;167:473-474.
Oh
P, Granich R, Scott J, Sun B, Joseph M, Stringfield C, Thisdell S, Staley
J, Workman-Malcolm D, Borenstein L, Lehnkering E, Ryan P, Soukup
J, Nitta A, Flood J.
Human exposure following Mycobacterium tuberculosis infection of multiple animal species in a
metropolitan zoo. Emerg Infect
Dis [serial online]2002 Nov;8. Available
online from URL: http://www.cdc.gov/ncidod/EID/vol8no11/02-0302.htm
Nitta AT, Knowles
LS, Kim J, Lehnkering EL,
Borenstein LA, Davidson PT,
Harvey SM, de Koning ML.
Limited transmission of multidrug-resistant tuberculosis despite a
high proportion of infectious cases in
Los
Angeles County
,
California
.
Am J Respir Crit Care Med
2002;165:812-817.
Nitta AT, Milligan D.
Management of four pregnant women with multidrug-resistant
tuberculosis. Clin Infect Dis 1999;28:1298-1304.
Ridzon R, Whitney
CG, McKenna MT, Taylor JP, Ashkar
SH, Nitta AT,
Harvey
SM, Valway S, Woodley C, Cooksey R, Onorato IM.
Risk factors for rifampin mono-resistant tuberculosis.
Am J Resp Crit Care Med
1998;157:1881-1884.
Nitta AT, Davidson
PT, Kilman RJ. Laboratory
errors and the misdiagnosis of tuberculosis (letter).
JAMA 1997;277:883.
Nitta AT, Davidson
PT, de Koning ML, Kilman
RJ. Misdiagnosis of multidrug-resistant
tuberculosis possibly due to laboratory-related errors. JAMA
1996;276:1980-1983.
Peloquin
CA
,
Nitta AT, Berning SE, Iseman
MD, James GT. Pharmacokinetic
evaluation of thiacetazone. Pharmacotherapy
1996;16:735-741.
Nitta, AT. Multidrug
resistant tuberculosis: how
far are we from
New York
City
(epitome). West J Med 1996;165:225-226.
Peloquin
CA, Nitta AT, Burman WJ,
Brudney KF, Miranda-Massari JR, McGuinness ME, Berning SE, Gerena GT.
Incidence of low anti-tuberculosis drug concentrations in patients
with AIDS. Ann
Pharmacother 1996;30:919-925.
Brown-Harrell
V, Nitta AT, Goble M.
Exacerbation of vitiligo syndrome due to clofazimine in a patient
with pulmonary Mycobacterium avium
complex disease (letter) [published erratum appears in Clin
Infect Dis 1996;22:1137]. Clin
Infect Dis 1996;22:581-582.
Stone MM, Vannier
AM,
Storch
SK
,
Peterson C, Nitta AT, Zhang Y.
Brief report: Meningitis
due to iatrogenic BCG infection in two immunocompromised children.
N Engl J Med 1995;333:561-563.
Peloquin CA, Henshaw TL, Huitt GA, Berning SE, Nitta
AT, James GT. Pharmacokinetic
evaluation of para-aminosalicylic
acid granules. Pharmacotherapy
1994;
14:40
-46.
Nitta AT, Iseman MD, Newell JD, Madsen LA,
Goble M. Ten-year experience
with artificial pneumoperitoneum for end-stage, drug-resistant pulmonary
tuberculosis. Clin
Infect Dis 1993;16:219-222.
|
Jobs
